Open AccessClopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery
Author(s) -
Hasan Karabulut
Publication year - 2004
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2003.11.037
Subject(s) - clopidogrel , medicine , perioperative , blood product , anesthesia , platelet , blood transfusion , artery , coronary artery bypass surgery , elective surgery , aspirin , prothrombin time , platelet transfusion , surgery
Platelet dysfunction is one of the major reasons of postoperative bleeding following coronary artery surgery. The aim of this study was to evaluate the effects of clopidogrel; a specific and potent irreversible inhibitor of platelet aggregation; on bleeding and use of blood and blood products after coronary artery bypass surgery (CABG).